title: Blood consult: acute myeloid leukemia and the t(8;21)(q22;22).
authors.affiliation: Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA.
authors.forename: Jae H
authors.initials: JH
authors.lastname: Park
authors.forename: Cyrus V
authors.initials: CV
authors.lastname: Hedvat
authors.forename: Martin S
authors.initials: MS
authors.lastname: Tallman
mesh_terms: D000595:Amino Acid Sequence; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001483:Base Sequence; D002891:Chromosomes, Human, Pair 21 / Q000235:genetics*; D002898:Chromosomes, Human, Pair 8 / Q000235:genetics*; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D006801:Humans; D016130:Immunophenotyping; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000235:genetics* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D020125:Mutation, Missense; D016133:Polymerase Chain Reaction; D019009:Proto-Oncogene Proteins c-kit / Q000235:genetics*
chemical_list: D003561:Cytarabine; D019009:Proto-Oncogene Proteins c-kit; D003630:Daunorubicin